Full Text View
Tabular View
No Study Results Posted
Related Studies
Emergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment
Expanded access is currently available for this treatment.
Verified by Boehringer Ingelheim Pharmaceuticals, November 2009
First Received: June 10, 2003   Last Updated: November 23, 2009   History of Changes
Sponsor: Boehringer Ingelheim Pharmaceuticals
Information provided by: Boehringer Ingelheim Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00062660
  Purpose

To provide early access to tipranavir and evaluate the safety and tolerance of tipranavir combined with low dose of ritonavir in patients with progressive, HIV-1 disease who have failed or are intolerant to currently approved treatments for HIV infection, who are unable to participate in another tipranavir controlled clinical trial and have an urgent need for anti-HIV treatment.


Condition Intervention
HIV Infections
Drug: Tipranavir Capsules
Drug: Tipranavir Oral Solution

Study Type: Expanded Access
Official Title: Emergency Use Program for Highly Treatment-Experienced HIV+ Patients

Resource links provided by NLM:


Further study details as provided by Boehringer Ingelheim Pharmaceuticals:

Study Start Date: May 2003
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   2 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- Patients aho have a positive serology HIV antibody test confirmed by Western blot, p24 antigen assay, HIV-1 RNA or HIV culture and are highly pre-treated and virus resistant to multiple protease inhibitors.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00062660

Contacts
Contact: Boehringer Ingelheim Study Coordinator 1-800-243-0127 clintriage.rdg@boehringer-ingelheim.com

  Hide Study Locations
Locations
United States, Arizona
1182.58.31 Completed
Scottsdale, Arizona, United States
United States, California
1182.58.03 Completed
San Francisco, California, United States
1182.58.29 Completed
Los Angeles, California, United States
1182.58.42 Synergy Hematology/Oncology Completed
Los Angeles, California, United States
1182.58.33 Kaiser Permanente Medical Center, Clinical Trials Unit Completed
San Francisco, California, United States
1182.58.34 Campus Code 696446 Completed
Los Angeles, California, United States
1182.58.43 Completed
Los Angeles, California, United States
United States, Connecticut
1182.58.37 AIDS Health Care Foundation Completed
Los Angeles, Connecticut, United States
1182.58.41 Circle Medical, LLC Completed
Norwalk, Connecticut, United States
United States, District of Columbia
1182.58.28 Completed
Washington, District of Columbia, United States
United States, Florida
1182.58.23 Hillsborough County Health Department Completed
Tampa, Florida, United States
1182.58.40 Drs. Raben and Feldman Research Associates Completed
South Miami, Florida, United States
1182.58.38 Completed
Miami Beach, Florida, United States
United States, Georgia
1182.58.36 Suite 525 Completed
Atlanta, Georgia, United States
United States, Hawaii
1182.58.08 Completed
Honolulu, Hawaii, United States
United States, Illinois
1182.58.22 Completed
Chicago, Illinois, United States
United States, Louisiana
1182.58.32 Completed
New Orleans, Louisiana, United States
United States, Massachusetts
1182.58.15 Completed
Boston, Massachusetts, United States
United States, Michigan
1182.58.19 Henry Ford Hospital Completed
Detroit, Michigan, United States
United States, Missouri
1182.58.04 Kansas City Free Health Clinic Completed
Kansas City, Missouri, United States
1182.58.25 Wohl Clinic Completed
St. Louis, Missouri, United States
United States, Nevada
1182.58.02 Wellness Center Completed
Las Vegas, Nevada, United States
United States, New York
1182.58.09 Polari Medical Group Completed
New York, New York, United States
United States, North Carolina
1182.58.30 Completed
Chapel Hill, North Carolina, United States
United States, Ohio
1182.58.06 University of Cincinnati Medical Center, Infectious diseases Completed
Cincinnati, Ohio, United States
United States, Oregon
1182.58.35 Completed
Portland, Oregon, United States
United States, Pennsylvania
1182.58.14 Completed
Philadelphia, Pennsylvania, United States
1182.58.20 University of Pittsburgh Completed
Pittsburgh, Pennsylvania, United States
United States, South Carolina
1182.58.01 Boehringer Ingelheim Investigational Site Completed
Columbia, South Carolina, United States
United States, Tennessee
1182.58.10 Comprehensive Care Center Completed
Nashville, Tennessee, United States
United States, Texas
1182.58.07 Completed
Houston, Texas, United States
1182.58.18 University of Texas Southwest Medical Center at Dallas Completed
Dallas, Texas, United States
1182.58.039 Olmos Park Medical Associates Completed
San Antonio, Texas, United States
United States, Washington
1182.58.11 Swedish Medical Center Completed
Seattle, Washington, United States
United States, Wisconsin
1182.58.44 VW Hospital and Clinics Completed
Madison, Wisconsin, United States
Australia, New South Wales
1182.58.61003 The Prince of Wales Hospital Completed
Randwick, New South Wales, Australia
1182.58.61008 St Vincents Hospital Completed
Darlinghurst, New South Wales, Australia
1182.58.61002 Royal North Shore Hospital Completed
St Leonards, New South Wales, Australia
1182.58.61005 Royal Prince Alfred Hospital Completed
Camperdown, New South Wales, Australia
1182.58.61006 Albion Street Clinic Completed
Surry Hills, New South Wales, Australia
1182.58.61025 Immunology Department Completed
Westmead, New South Wales, Australia
1182.58.61012 Bigge Park Centre Completed
Liverpool, New South Wales, Australia
1182.58.61011 St Vincents Hospital Completed
Darlinghurst, New South Wales, Australia
1182.58.61007 407 Doctors Pty Ltd Completed
Darlinghusrst, New South Wales, Australia
1182.58.61019 407 Bouke Street Completed
Darlinghusrst, New South Wales, Australia
1182.58.61014 St Vincents Hospital Completed
Darlinghurst, New South Wales, Australia
1182.58.61022 Sexual Health Clinic Completed
Kingswood, New South Wales, Australia
Australia, Queensland
1182.58.61016 Princess Alexandra Hospital Completed
Woolloongabba, Queensland, Australia
1182.58.61024 Completed
Nambour, Queensland, Australia
1182.58.61009 Level 6 Completed
Herston, Queensland, Australia
1182.58.61010 Biala Building Completed
Brisbane, Queensland, Australia
Australia, South Australia
1182.58.61020 Completed
Adelaide, South Australia, Australia
1182.58.61015 Flinders Medical Centre Completed
Bedford Park, South Australia, Australia
Australia, Victoria
1182.58.61001 88 Rathdowne Street Carlton Completed
Carlton, Victoria, Australia
1182.58.61017 Department of Infectious Diseases Completed
Clayton, Victoria, Australia
1182.58.61023 Completed
Melbourne, Victoria, Australia
1182.58.61013 Melbourne Sexual Health Clinic Completed
Melbourne, Victoria, Australia
1182.58.61018 Melbourne Sexual Health Clinic Completed
Carlton, Victoria, Australia
1182.58.61021 Completed
South Yarra, Victoria, Australia
Australia, Western Australia
1182.58.61004 Royal Perth Hospital Completed
Perth, Western Australia, Australia
Belgium
1182.58.3201 Boehringer Ingelheim Investigational Site Completed
Antwerpen, Belgium
1182.58.3202 Boehringer Ingelheim Investigational Site Completed
Bruxelles, Belgium
1182.58.3204 Boehringer Ingelheim Investigational Site Completed
Liège, Belgium
1182.58.3203 Boehringer Ingelheim Investigational Site Completed
Bruxelles, Belgium
Denmark
1182.58.4501 Afsnit M 5112 Completed
Copenhagen Ø, Denmark
1182.58.4504 C Ambulatoriet Completed
Odense C, Denmark
1182.58.4505 Infektionsmedicinsk ambulatorie Q Completed
Århus C, Denmark
France
1182.58.33001 Hôpital Saint Jacques Completed
Besançon Cedex, France
1182.58.33002 Hôpital Purpan Completed
Toulouse Cedex 9, France
1182.58.33003 Hôpital de l'Archet Completed
Nice Cedex 3, France
1182.58.33005 Hôpital Bichat Completed
Paris Cedex 18, France
1182.58.33006 Hôpital Bicêtre Completed
Le Kremlin Bicêtre Cedex, France
1182.58.33007 Hôpital Georges Pompidou Completed
Paris Cedex 15, France
1182.58.33008 Hôpital Hôtel Dieu Completed
Nantes Cedex 1, France
1182.58.33009 Hôpital de la Conception Completed
Marseille Cedex 5, France
1182.58.33010 Hôpital Brabois Completed
Vandoeuvre Les Nancy, France
1182.58.33022 Hôpital Avicenne Completed
Bobigny Cedex, France
1182.58.33023 Hôpital Sainte Marguerite Completed
Marseille Cedex 9, France
1182.58.33024 Hôpital Necker Completed
Paris, France
1182.58.33033 Hôpital Tenon Completed
Paris Cedex 20, France
1182.58.33026 Hôpital Ponchaillou Completed
Rennes Cedex 9, France
1182.58.33027 Hôpital Completed
Dijon Cedex, France
1182.58.33028 Hôpital Louis Mourier Completed
Colombes, France
1182.58.33029 Hôpital Aix Completed
Aix En Provence Cedex 1, France
1182.58.33030 Hôpital Saint Eloi Completed
Montpellier, France
1182.58.33031 Hôpital edouard Herriot Completed
Lyon Cedex 3, France
1182.58.33032 Hôpital Emile Muller Completed
Mulhouse Cedex 1, France
1182.58.33025 Hôpital Foch Recruiting
Suresnes Cedex, France
1182.58.33034 Hôpital Raymond Poincarré Completed
Garches, France
1182.58.33011 Hôpital Paul Brousse Completed
Villejuif Cedex, France
1182.58.33012 Hôpital Robert Debré Completed
Reims Cedex, France
1182.58.33014 Hôpital Cochin Completed
Paris Cedex 14, France
1182.58.33015 Hôpital Civil Completed
Strasbourg Cedex, France
1182.58.33019 Hôpital de l'Hôtel Dieu Completed
Lyon Cedex 2, France
1182.58.33017 Hôpital Bichat Claude Bernard Completed
Paris Cedex 18, France
1182.58.33018 Hôpital Saint Antoine Completed
Paris, France
1182.58.33016 Completed
Tourcoing, France
1182.58.33020 Hôpital Antoine Beclère Completed
Clamart Cedex, France
1182.58.33021 Hôpital Chalucet Completed
Toulon Cedex, France
1182.58.33013 Hôpital Saint Louis Completed
Paris Cedex 10, France
1182.58.33035 Hôpital des Abîmes Completed
Pointe A Pitre, France
Greece
1182.58.3001 Completed
Athens, Greece
Ireland
1182.58.44016 St James Hospital, Dept of Genito Urinary Medicine Completed
Dublin, Ireland
1182.58.44029 Our Lady For Sick Children Completed
Dublin 12, Ireland
Italy
1182.58.3901 Ospedale Luigi Sacco Completed
Milano, Italy
1182.58.3902 Ospedale L. Sacco Completed
Milano, Italy
1182.58.3903 Università di Brescia Completed
Brescia, Italy
1182.58.3904 Ospedali Riuniti di Foggia Completed
Foggia, Italy
1182.58.3905 Presidio Dalmati Completed
S. Angelo Lodigiano (lo), Italy
1182.58.3906 Ospedale Infantile Regina Margherita Completed
Torino, Italy
1182.58.3907 Presidio Ospedaliero di Rimini Completed
Rimini, Italy
1182.58.3908 Centro Medicina Preventiva Completed
Verona, Italy
Portugal
1182.58.35102 Hospital de dia de Doenças Infecciosas Recruiting
Cascais, Portugal
Switzerland
1182.58.4101 Boehringer Ingelheim Investigational Site Completed
Basel, Switzerland
1182.58.4103 Boehringer Ingelheim Investigational Site Completed
Bern, Switzerland
1182.58.4104 Boehringer Ingelheim Investigational Site Completed
Genève, Switzerland
1182.58.4105 Boehringer Ingelheim Investigational Site Completed
Zürich, Switzerland
1182.58.4107 Boehringer Ingelheim Investigational Site Recruiting
Genève, Switzerland
1182.58.4102 Boehringer Ingelheim Investigational Site Completed
Zürich, Switzerland
United Kingdom
1182.58.44002 Boehringer Ingelheim Investigational Site Completed
Cardiff, United Kingdom
1182.58.44003 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44004 Boehringer Ingelheim Investigational Site Completed
Brighton, United Kingdom
1182.58.44005 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44010 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44031 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44014 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44008 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44009 Boehringer Ingelheim Investigational Site Completed
Edinburgh, United Kingdom
1182.58.44017 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44023 Boehringer Ingelheim Investigational Site Completed
Harrow, United Kingdom
1182.58.44024 Boehringer Ingelheim Investigational Site Completed
Leeds, United Kingdom
1182.58.44025 Boehringer Ingelheim Investigational Site Completed
Chertsey, United Kingdom
1182.58.44026 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44027 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44028 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44018 Boehringer Ingelheim Investigational Site Completed
London, United Kingdom
1182.58.44019 Boehringer Ingelheim Investigational Site Completed
Chichester, United Kingdom
1182.58.44020 Beckenham Hospital Completed
Beckenham, United Kingdom
1182.58.44022 Boehringer Ingelheim Investigational Site Completed
Woolwich, United Kingdom
1182.58.44030 Boehringer Ingelheim Investigational Site Completed
Woolwich, United Kingdom
1182.58.44011 Boehringer Ingelheim Investigational Site Completed
Peterborough, United Kingdom
Sponsors and Collaborators
Boehringer Ingelheim Pharmaceuticals
Investigators
Study Chair: Boehringer Ingelheim Boehringer Ingelheim Pharmaceuticals
  More Information

No publications provided

Responsible Party: Boehringer Ingelheim ( Boehringer Ingelheim, Study Chair )
Study ID Numbers: 1182.58
Study First Received: June 10, 2003
Last Updated: November 23, 2009
ClinicalTrials.gov Identifier: NCT00062660     History of Changes
Health Authority: Australia:;   Austria: Federal Ministry for Health and Women;   Belgium: Federal Agency for Medicines and Health Products;   Canada: Health Canada;   Denmark: The Ministry of the Interior and Health;   France: Ministry of Health;   Great Britain:;   Ireland: Ministry of Health;   Italy: Ministry of Health;   Netherlands: Ministry of Health, Welfare and Sport;   Portugal: National Pharmacy and Medicines Institute;   Romania: Ministry of Public Health;   South Africa:;   Spain: Ministry of Health;   Switzerland: Federal Office of Public Health;   United States: Food and Drug Administration

Additional relevant MeSH terms:
Anti-Infective Agents
Disease Attributes
RNA Virus Infections
Sexually Transmitted Diseases, Viral
Anti-HIV Agents
Slow Virus Diseases
Immune System Diseases
Acquired Immunodeficiency Syndrome
Infection
Antiviral Agents
Pharmacologic Actions
Immunologic Deficiency Syndromes
Tipranavir
Virus Diseases
Pathologic Processes
Anti-Retroviral Agents
HIV Infections
Therapeutic Uses
Sexually Transmitted Diseases
Lentivirus Infections
Emergencies
Retroviridae Infections

ClinicalTrials.gov processed this record on November 27, 2009